LTAS
RARE icon

Linden Thomas Advisory Services’s Ultragenyx Pharmaceutical RARE Stock Holding History

Linden Thomas Advisory Services’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6,172
Closed -$285K – 414
2023
Q2 		$285K Sell
6,172
-66
-1% -$3.05K 0.06% 328
2023
Q1 		$250K Buy
6,238
+490
+9% +$19.6K 0.06% 320
2022
Q4 		$266K Buy
+5,748
New +$266K 0.08% 318